List of insiders holdings for Translate Bio Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| Sanofi 10% Owner | 2021-09-14 09:59:09 | 75,668,031 0 | 75,668,031 | Form 4 |
| BAUPOST GROUP LLC Baupost Group GP L.L.C. KLARMAN SETH A 10% Owner | 2021-09-16 17:43:14 | 0 18,044,239 | 18,044,239 | Form 4/A |
| Shire Human Genetic Therapies Inc. Shire plc 10% Owner | 2018-07-02 21:46:18 | 7,262,564 0 | 7,262,564 | Form 4 |
| Atlas Venture Fund VIII L.P. Atlas Venture Associates VIII L.P. Atlas Venture Associates VIII Inc. 10% Owner | 2021-02-02 13:01:00 | 3,922,008 0 | 3,922,008 | Form 13G |
| Gallagher Brian M. Jr. Director | 2018-07-05 16:30:24 | 0 3,697,912 | 3,697,912 | Form 4 |
| Omega Fund IV L.P. Omega Fund IV GP L.P. Omega Fund IV G.P. Manager Ltd. Omega Fund V L.P. Omega Fund V GP L.P. Omega Fund V GP Manager Ltd. Stampacchia Otello Lim Richard J. Paster Anne-Mari Nessi Claudio 10% Owner | 2020-02-14 11:02:06 | 2,437,603 0 | 2,437,603 | Form 13G |
| MRL Ventures Fund LLC 10% Owner | 2018-07-03 18:44:34 | 1,873,503 0 | 1,873,503 | Form 4 |
| GLAXOSMITHKLINE PLC 10% Owner | 2020-02-14 16:40:57 | 646,541 0 | 646,541 | Form 13D |
| LYNCH DANIEL Director | 2021-02-16 16:12:26 | 221,825 0 | 221,825 | Form 5 |
| Heartlein Michael Chief Scientific Officer | 2019-03-12 18:13:27 | 150,000 0 | 150,000 | Form 4 |
| Schroer John R. Chief Financial Officer | 2020-03-05 19:54:54 | 150,000 0 | 150,000 | Form 4 |
| Fenton Brian Chief Business Officer | 2019-03-12 18:12:32 | 90,000 0 | 90,000 | Form 4 |
| Barbier Ann Chief Medical Officer | 2021-03-09 20:24:32 | 70,000 0 | 70,000 | Form 4 |
| Wooster Richard Chief Scientific Officer | 2021-03-09 20:26:10 | 70,000 0 | 70,000 | Form 4 |
| Cloghessy Paula Chief Human Resources Officer | 2019-03-12 18:11:30 | 60,000 0 | 60,000 | Form 4 |
| Beckman Daniella Director | 2021-09-14 19:19:11 | 0 0 | 0 | Form 4 |
| FORMELA JEAN FRANCOIS Director | 2021-09-14 19:23:37 | 0 0 | 0 | Form 4 |
| Demetri George Director | 2021-09-14 19:25:01 | 0 0 | 0 | Form 4 |
| Hughes Owen Director | 2021-09-14 19:26:06 | 0 0 | 0 | Form 4 |
| Meyer Robert J. Director | 2021-09-14 19:27:02 | 0 0 | 0 | Form 4 |
| Plenge Robert M Director | 2021-09-14 19:28:19 | 0 0 | 0 | Form 4 |
| Burgess Paul D. Chief Operating Officer, CLO | 2021-09-14 19:29:46 | 0 0 | 0 | Form 4 |
| Renaud Ronald C JR Chief Executive Officer | 2021-09-14 19:32:44 | 0 0 | 0 | Form 4 |
| Smith Brendan Chief Financial Officer | 2021-09-14 19:33:46 | 0 0 | 0 | Form 4 |
| Sutherland Everett Rand President | 2021-09-14 19:34:57 | 0 0 | 0 | Form 4 |
| Shire Human Genetic Therapies Inc. TAKEDA PHARMACEUTICAL CO LTD 10% Owner | 2021-01-25 06:07:39 | 0 0 | 0 | Form 13G |